Clues on Why LAI Antipsychotics Are Underutilized in Schizophrenia
(MedPage Today) -- COLORADO SPRINGS, Colo.--The belief that long-acting injectable (LAI) antipsychotics for schizophrenia should be reserved for patients with severe symptoms or adherence issues may be contributing to their underutilization...
Read more »